By solving the atomic structure of the transcription factor Rho of Mycobacterium tuberculosis by cryoEM, researchers from CBM and CBS (Montpellier) have identified a mutation specifically responsible for resistance to bicyclomycin in this pathogen.
A lire aussi
A new anticancer therapeutic strategy targeting the protein kinases LIMKs via new innovative chemical compounds
29 October 2024
par Isabelle Frapart
2024, November 15 - Seminar of Gyula TIRCSO
25 October 2024
par Isabelle Frapart
2024, November 8 - Seminar of Sophia MISSOURRY
25 October 2024
par Isabelle Frapart